These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8535652)

  • 1. Sulphasalazine: mechanism of action in rheumatoid arthritis.
    Smedegård G; Björk J
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():7-15. PubMed ID: 8535652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism.
    Cronstein BN
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():30-2. PubMed ID: 8535646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine in rheumatic diseases.
    Dougados M
    Agents Actions Suppl; 1993; 44():197-201. PubMed ID: 8103962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of sulphasalazine--a review.
    Capell HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():35-9. PubMed ID: 8535647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between AIF-1 gene polymorphisms and response to rheumatoid arthritis treatment with sulphasalazine].
    Dabrowska-Zamojcin E; Herczyńska MM; Pawlik A
    Ann Acad Med Stetin; 2013; 59(2):39-42. PubMed ID: 25026748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological agents in rheumatoid arthritis.
    Shankar S; Handa R
    J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.
    Tian H; Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M; Verhoeven AC; van der Linden S
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern drug treatment options for rheumatoid arthritis.
    Binning M
    Aust Nurs J; 2001 Apr; 8(9):suppl 1-3. PubMed ID: 11894377
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulfasalazine in rheumatology].
    Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
    Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
    Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
    Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of biologicals in the treatment of rheumatoid arthritis. a meta-analysis.
    Venkateshan SP; Sidhu S; Malhotra S; Pandhi P
    Pharmacology; 2009; 83(1):1-9. PubMed ID: 18957873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antirheumatic drugs and gene signatures.
    Ospelt C; Gay S
    Curr Opin Investig Drugs; 2007 May; 8(5):385-9. PubMed ID: 17520867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis.
    Ramsburg KL
    Am J Nurs; 2000 Nov; 100(11):40-3. PubMed ID: 11103634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.